Share on StockTwits

RXi Pharmaceuticals Corp (NASDAQ:RXII) CEO Geert Cauwenbergh bought 2,000 shares of RXi Pharmaceuticals Corp stock in a transaction dated Wednesday, July 2nd. The shares were purchased at an average price of $2.86 per share, for a total transaction of $5,720.00. Following the completion of the purchase, the chief executive officer now directly owns 28,600 shares in the company, valued at approximately $81,796. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

RXi Pharmaceuticals Corp (NASDAQ:RXII) opened at 2.95 on Friday. RXi Pharmaceuticals Corp has a 1-year low of $2.55 and a 1-year high of $6.84. The stock has a 50-day moving average of $2.95 and a 200-day moving average of $3.94. The company’s market cap is $41.4 million.

RXi Pharmaceuticals Corp (NASDAQ:RXII) last released its earnings data on Wednesday, May 14th. The company reported ($0.32) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.31) by $0.01. Analysts expect that RXi Pharmaceuticals Corp will post $-0.89 EPS for the current fiscal year.

A number of analysts have recently weighed in on RXII shares. Analysts at Laidlaw initiated coverage on shares of RXi Pharmaceuticals Corp in a research note on Monday, June 2nd. They set a “buy” rating and a $8.00 price target on the stock. Separately, analysts at Wainwright initiated coverage on shares of RXi Pharmaceuticals Corp in a research note on Monday, May 5th. They set a “buy” rating and a $9.00 price target on the stock. Finally, analysts at HC Wainwright initiated coverage on shares of RXi Pharmaceuticals Corp in a research note on Monday, May 5th. They set a “buy” rating and a $9.00 price target on the stock.

RXi Pharmaceuticals Corporation (NASDAQ:RXII) is a development-stage company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.